Provided by Tiger Fintech (Singapore) Pte. Ltd.

Abbott Laboratories

133.58
-0.3600-0.27%
Post-market: 134.230.6467+0.48%18:51 EDT
Volume:3.87M
Turnover:517.48M
Market Cap:232.41B
PE:17.34
High:135.22
Open:134.79
Low:133.10
Close:133.94
Loading ...
May 02, 2022

Major Issues Report

8-K - Current report
Apr 20, 2022

Major Issues Report

8-K - Current report
Feb 22, 2022

Major Issues Report

8-K - Current report
Feb 18, 2022

Major Issues Report

8-K - Current report
Feb 18, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jan 31, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jan 26, 2022

Major Issues Report

8-K - Current report
Dec 13, 2021

Major Issues Report

8-K - Current report
Dec 10, 2021

Major Issues Report

8-K - Current report
Dec 08, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Dec 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 17, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 17, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 17, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 27, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 27, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities